Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


27.11.2017

1 Acta Neurol Scand
2 BMC Neurol
3 Intern Med
1 J Immunol
9 J Neuroimmunol
3 J Neurol
1 Mult Scler


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. IBRAHIM J, Grapperon AM, Manfredonia F, van den Bergh PY, et al
    Serial electrophysiology in Guillain-Barre syndrome: A retrospective cohort and case-by-case multicentre analysis.
    Acta Neurol Scand. 2017 Nov 21. doi: 10.1111/ane.12872.
    PubMed     Text format     Abstract available


    BMC Neurol

  2. NAUTA IM, Speckens AEM, Kessels RPC, Geurts JJG, et al
    Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): a study protocol for a randomised controlled trial.
    BMC Neurol. 2017;17:201.
    PubMed     Text format     Abstract available

  3. WANG Y, Shang P, Xin M, Bai J, et al
    The usefulness of chief complaints to predict severity, ventilator dependence, treatment option, and short-term outcome of patients with Guillain-Barre syndrome: a retrospective study.
    BMC Neurol. 2017;17:200.
    PubMed     Text format     Abstract available


    Intern Med

  4. KOMURA T, Ohta H, Seike T, Shimizu Y, et al
    The Efficacy of Corticosteroid Therapy in a Patient with Nonalcoholic Steatohepatitis Overlapping Autoimmune Hepatitis: A Case Report.
    Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.8887.
    PubMed     Text format     Abstract available

  5. NAWATA T, Kubo M, Mitsui H, Oishi K, et al
    A Case of Dermatomyositis Complicated by Digital Ischemia and Lung Adenocarcinoma in a Patient with Positive Anti-signal Recognition Particle Antibodies.
    Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.9307.
    PubMed     Text format     Abstract available

  6. OMOTO S, Utsumi T, Matsuno H, Terasawa Y, et al
    Thrombotic Microangiopathy Presenting with Intestinal Involvement Following Long-term Interferon-beta1b Treatment for Multiple Sclerosis.
    Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.9326.
    PubMed     Text format     Abstract available


    J Immunol

  7. HUANG W, Rainbow DB, Wu Y, Adams D, et al
    A Novel Pkhd1 Mutation Interacts with the Nonobese 1Diabetic Genetic Background To Cause Autoimmune Cholangitis.
    J Immunol. 2017 Nov 20. pii: ji1701087. doi: 10.4049/jimmunol.1701087.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  8. ROLF L, Muris AH, Theunissen R, Hupperts R, et al
    Vitamin D3 supplementation and the IL-2/IL-2R pathway in multiple sclerosis: Attenuation of progressive disturbances?
    J Neuroimmunol. 2017 Nov 10. pii: S0165-5728(17)30208.
    PubMed     Text format     Abstract available

  9. AKAISHI T, Kaneko K, Himori N, Takeshita T, et al
    Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica.
    J Neuroimmunol. 2017;313:10-15.
    PubMed     Text format     Abstract available

  10. LIU J, Lian Z, Chen H, Shi Z, et al
    Associations between tumor necrosis factor-alpha gene polymorphisms and the risk of Guillain-Barre syndrome and its subtypes: A systematic review and meta-analysis.
    J Neuroimmunol. 2017;313:25-33.
    PubMed     Text format     Abstract available

  11. GILLI F, Royce DB, DiSano KD, Pachner AR, et al
    Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis.
    J Neuroimmunol. 2017;313:34-40.
    PubMed     Text format     Abstract available

  12. LI R, Sun X, Shu Y, Wang Y, et al
    Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients.
    J Neuroimmunol. 2017;313:56-60.
    PubMed     Text format     Abstract available

  13. TAYLOR JM
    Tissue resident macrophages are sufficient for demyelination during peripheral nerve myelin induced experimental autoimmune neuritis?
    J Neuroimmunol. 2017;313:69-76.
    PubMed     Text format     Abstract available

  14. BHAT R, Mahapatra S, Axtell RC, Steinman L, et al
    Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine.
    J Neuroimmunol. 2017;313:77-81.
    PubMed     Text format     Abstract available

  15. ROLLA S, De Mercanti SF, Bardina V, Horakova D, et al
    Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses.
    J Neuroimmunol. 2017;313:89-91.
    PubMed     Text format     Abstract available

  16. MAZDEH M, Moradi N, Khoshroo E, Shayesteh Z, et al
    Down-regulation of TYK2, CBLB and LMP7 genes expression in relapsing-remitting multiple sclerosis patients treated with interferon-beta.
    J Neuroimmunol. 2017 Nov 8. pii: S0165-5728(17)30405.
    PubMed     Text format     Abstract available


    J Neurol

  17. THALER C, Faizy TD, Sedlacik J, Bester M, et al
    The use of multiparametric quantitative magnetic resonance imaging for evaluating visually assigned lesion groups in patients with multiple sclerosis.
    J Neurol. 2017 Nov 20. doi: 10.1007/s00415-017-8683.
    PubMed     Text format     Abstract available

  18. CONRADSSON D, Ytterberg C, von Koch L, Johansson S, et al
    Changes in disability in people with multiple sclerosis: a 10-year prospective study.
    J Neurol. 2017 Nov 20. doi: 10.1007/s00415-017-8676.
    PubMed     Text format     Abstract available

  19. ELIASDOTTIR O, Hildeman A, Longfils M, Nerman O, et al
    A nationwide survey of the influence of month of birth on the risk of developing multiple sclerosis in Sweden and Iceland.
    J Neurol. 2017 Nov 20. doi: 10.1007/s00415-017-8665.
    PubMed     Text format     Abstract available


    Mult Scler

  20. SPITERI S, Hassa T, Claros-Salinas D, Dettmers C, et al
    Neural correlates of effort-dependent and effort-independent cognitive fatigue components in patients with multiple sclerosis.
    Mult Scler. 2017 Nov 1:1352458517743090. doi: 10.1177/1352458517743090.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: